Study title: Multicenter, double-blind, multiple-dose, placebo-controlled dose-response study of ebastine in children with seasonal ragweed allergy
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: EBASTINE | |||||
ATC code: | |||||
Document link: RP-64305X-106_Ebastine_EUdraCT_reduced datafields-CP-Almirall.xls | |||||
Document date: 2013-07-24 | |||||
Study number: RP-64305X-106 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |